BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17261500)

  • 21. Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
    Gelber RD; Sallan SE; Cohen HJ; Donnelly M; Dalton V; Tobia F; Clavell LA; Tarbell NJ
    Cancer; 1993 Jul; 72(1):261-70. PubMed ID: 8508416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The significance of an isolated central nervous system relapse, occurring as first relapse in children with acute lymphoblastic leukemia.
    Behrendt H; van Leeuwen EF; Schuwirth C; Verkes RJ; Hermans J; van der Does-van den Berg A; van Wering ER
    Cancer; 1989 May; 63(10):2066-72. PubMed ID: 2702576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of central nervous system involvement at diagnosis of childhood T-cell acute lymphoblastic leukemia.
    Jaing TH; Yang CP; Hung IJ; Tsay PK; Tseng CK; Chen SH
    Pediatr Blood Cancer; 2005 Aug; 45(2):135-8. PubMed ID: 15704218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
    Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
    J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985-1989.
    von der Weid N; Wagner B; Angst R; Arnet B; Baumgartner C; Beck D; Bleher A; Caflisch U; Delaleu B; Feldges A
    Med Pediatr Oncol; 1994; 22(6):361-9. PubMed ID: 8152396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
    Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
    N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
    Jastaniah W; Elimam N; Abdalla K; Khattab TM; Felimban S; Abrar MB
    Hematology; 2015 Dec; 20(10):561-6. PubMed ID: 26010408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia.
    Behrendt H; van Leeuwen EF; Schuwirth C; Verkes RJ; Hermans J; van der Does-van den Berg A; van Wering ER
    Med Pediatr Oncol; 1990; 18(3):190-6. PubMed ID: 2329963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome after first relapse in children with acute lymphoblastic leukemia: a report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol.
    van den Berg H; de Groot-Kruseman HA; Damen-Korbijn CM; de Bont ES; Schouten-van Meeteren AY; Hoogerbrugge PM
    Pediatr Blood Cancer; 2011 Aug; 57(2):210-6. PubMed ID: 21337680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of recurrence in children with acute lymphatic leukemia].
    Behrendt H; van Leeuwen EF; Schuwirth C; Verkes RJ; Hermans J; van der Does-van den Berg A; van Wering ER
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):67-72. PubMed ID: 3163855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical indications for identical pathogenesis of isolated and non-isolated testicular relapses in acute lymphoblastic leukaemia.
    Jahnukainen K; Salmi TT; Kristinsson J; Müller J; Madsen B; Gustafsson G
    Acta Paediatr; 1998 Jun; 87(6):638-43. PubMed ID: 9686656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia.
    Levinsen M; Taskinen M; Abrahamsson J; Forestier E; Frandsen TL; Harila-Saari A; Heyman M; Jonsson OG; Lähteenmäki PM; Lausen B; Vaitkevičienė G; Asberg A; Schmiegelow K;
    Pediatr Blood Cancer; 2014 Aug; 61(8):1416-21. PubMed ID: 24623619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
    Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications and Management of Central Nervous System Involvement before Allogeneic Hematopoietic Cell Transplantation in Acute Lymphoblastic Leukemia.
    Aldoss I; Al Malki MM; Stiller T; Cao T; Sanchez JF; Palmer J; Forman SJ; Pullarkat V
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):575-8. PubMed ID: 26493564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
    Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
    Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
    Veerman AJ; Hählen K; Kamps WA; Van Leeuwen EF; De Vaan GA; Solbu G; Suciu S; Van Wering ER; Van der Does-Van der Berg A
    J Clin Oncol; 1996 Mar; 14(3):911-8. PubMed ID: 8622039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999.
    Tsuchida M; Ohara A; Manabe A; Kumagai M; Shimada H; Kikuchi A; Mori T; Saito M; Akiyama M; Fukushima T; Koike K; Shiobara M; Ogawa C; Kanazawa T; Noguchi Y; Oota S; Okimoto Y; Yabe H; Kajiwara M; Tomizawa D; Ko K; Sugita K; Kaneko T; Maeda M; Inukai T; Goto H; Takahashi H; Isoyama K; Hayashi Y; Hosoya R; Hanada R;
    Leukemia; 2010 Feb; 24(2):383-96. PubMed ID: 20033052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multi-center trial based on SCMC-ALL-2005 for children's acute lymphoblastic leukemia].
    SHAQ Multicenter Study Group of Children's Acute Lymphoblastic Leukemia Research
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):495-501. PubMed ID: 24267129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.